Author

S. H. L. Verhelst

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. D. Garg· 1 shared C. Van den Haute· 1 shared D. Korovesis· 1 shared F. Finotello· 1 shared J. Coene· 1 shared J. Eggermont· 1 shared J. Rozanc· 1 shared L. Alexopoulos· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. D. Garg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivDec 15, 2022

Novel green fluorescent polyamines to analyze ATP13A2 and ATP13A3 activity in the mammalian polyamine transport system

M. C. Houdou, N. Jacobs, J. Coene…·P. Vangheluwe

The paper develops green fluorescent polyamine analogs to study ATP13A2 and ATP13A3 polyamine transport activity and identifies structure-activity relationships for isoform-specific transport.

DOI 10.3390/biom13020337

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 24, 2020

The IRE1 Inhibitor KIRA6 Curtails The Inflammatory Trait Of Immunogenic Anticancer Treatments By Targeting HSP60 Independent Of IRE1

N. Rufo, D. Korovesis, S. van Eygen…·P. Agostinis

The paper shows KIRA6 reduces inflammation from immunogenic cancer treatments by targeting HSP60, not through IRE1 inhibition.

DOI 10.1101/2020.12.24.424330

humanbulk RNA-seq

𝕏 PostBluesky